Publication:
Effect of pharmacist-led patient education on adherence to tuberculosis treatment

dc.contributor.authorRABUŞ, ŞULE
dc.contributor.authorsClark, Philip M.; Karagoz, Turan; Apikoglu-Rabus, Sule; Izzettin, Fikret Vehbi
dc.date.accessioned2022-03-12T17:33:00Z
dc.date.accessioned2026-01-10T18:42:23Z
dc.date.available2022-03-12T17:33:00Z
dc.date.issued2007
dc.description.abstractPurpose. The purpose of this study was to assess the effect of a clinical pharmacist-directed patient education program on the therapy adherence of first-time tuberculosis (TB) patients and to identify the major pharmaceutical care needs and issues of first-time TB and multidrug-resistant (MDR)-TB patients. Methods. In the first part of the study, first-time TB patients were randomized either to the No EDU group (n = 58) where patients received routine medical and nursing care or to the EDU group (n = 56) where patients were also provided with clinical pharmacist-directed patient education. The patient's adherence to treatment was evaluated by attendance at scheduled visits, medication counting, and urine analysis for the presence of isoniazid metabolites. In the second part of the study, the pharmaceutical care needs and issues were determined for first-time TB patients and for MDR-TB patients (n = 40). Results. The adherence of patients who received pharmacist-directed patient education was greater than that of patients who did not. The attendance at scheduled visits and urine analysis for the presence of isoniazid metabolites yielded better results in respect to adherence for the EDU group (p < 0.05), while medication counting did not differ between the two groups. The major pharmaceutical care needs of first-time TB patients were for pain control, nutrient replacement, appropriate prescribing, respiratory control, and diabetic control. Similar findings were recorded for MDR-TB patients. Conclusion. Patients' adherence to TB treatment improved when a pharmacist provided patient education on medication use and addressed patients' pharmaceutical care issues.
dc.identifier.doi10.2146/ajhp050543
dc.identifier.eissn1535-2900
dc.identifier.issn1079-2082
dc.identifier.pubmed17322163
dc.identifier.urihttps://hdl.handle.net/11424/228745
dc.identifier.wosWOS:000244878300012
dc.language.isoeng
dc.publisherAMER SOC HEALTH-SYSTEM PHARMACISTS
dc.relation.ispartofAMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectantituberculars
dc.subjectclinical pharmacists
dc.subjectcompliance
dc.subjectisoniazid
dc.subjectpatient information
dc.subjectpatients
dc.subjectpharmaceutical care
dc.subjectrational therapy
dc.subjectresistance
dc.subjecttuberculosis
dc.subjectMULTIDRUG-RESISTANT TUBERCULOSIS
dc.subjectDRUG
dc.subjectPROSPECTS
dc.subjectTHERAPY
dc.subjectSMOKING
dc.subjectPROGRAM
dc.subjectTURKEY
dc.subjectURINE
dc.titleEffect of pharmacist-led patient education on adherence to tuberculosis treatment
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage506
oaire.citation.issue5
oaire.citation.startPage497
oaire.citation.titleAMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
oaire.citation.volume64

Files